MICAL-L2 has been reported to mediate the endocytic recycling of occludin [42], while we have also recently shown that MICAL-L2 promotes the migration of gastric cancer cells via inhibiting EGFR transportation and degradation [10]. The gene discussed is MICALL2; the disease is gastric cancer.